Papers: 10.1371/journal.ppat.1008795

https://doi.org/10.1371/journal.ppat.1008795

An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection

Cited by: 26
Author(s): Kevin P. Egan, Lauren M. Hook, Alexis Naughton, Norbert Pardi, Sita Awasthi, Gary H. Cohen, Drew Weissman, Harvey M. Friedman
Published: over 6 years ago

Software Mentions 1